Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.
Press releases published on May 19, 2025

Duck Creek Technologies Mengumumkan Tyler Jones sebagai Ketua Pegawai Pemasaran Baharu
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, sebuah syarikat penyedia penyelesaian pintar yang membentuk masa depan insurans harta benda dan kasualti (P…

Duck Creek Technologies Nomeia Tyler Jones como Diretor de Marketing
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- A Duck Creek Technologies, fornecedora de soluções inteligentes que definem o futuro do seguro de propriedade e acidentes (P…

Duck Creek Technologies ประกาศแต่งตั้ง Tyler Jones เป็นประธานเจ้าหน้าที่ฝ่ายการตลาด
บอสตัน, May 19, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies ผู้ให้บริการโซลูชันอัจฉริยะระดับโลกผู้กำหนดอนาคตของทรัพย์สินและอุบัติเหตุ (P…

Duck Creek Technologies 宣布任命 Tyler Jones 为首席营销官
波士顿, May 19, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies,一家定义财产与意外险 (P…

Duck Creek Technologies 宣布 Tyler Jones 任行銷總監
波士頓, May 19, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies 是一家引領財產及意外險 (P…

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair
NORWOOD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced the appointment of Rachelle Jacques as Chair of its Board of Directors, …

Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 gene therapy BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on …

Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
Files Investor Presentation and Issues Open Letter to Stockholders Urges Stockholders to Protect the Value of Their Investment by Voting “FOR” Each of the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Keros …

Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
First-in-human study will evaluate safety, tolerability, and early efficacy of a one-time, pancreas-targeted smart GLP-1TM gene therapy for patients with inadequately controlled T2D and obesity Expect to dose first patients and report preliminary data in …

Rejuvenate Biomed Doses First Patient in Phase 2 Trial on COPD-related Muscle Weakness and Sarcopenia
DIEPENBEEK, Belgium, May 19, 2025 (GLOBE NEWSWIRE) -- Rejuvenate Biomed, an AI-enabled, clinical-stage biotech company developing safe, synergistic combination therapeutics that alter the course of age-related diseases, announced today that the first …

Lifeward to Present at Sidoti Virtual Investor Conference on May 21
MARLBOROUGH, Mass., and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward, Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …

Lakeside Software Unveils SysTrack Mobile Experience: Delivering Real-Time IT Analytics and Telemetry to Mobile Devices
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Lakeside Software, the first AI-driven digital employee experience company, today announced the SysTrack Mobile Experience, which delivers real-time IT telemetry, natural language querying, and context-aware …

Lakeside Software stellt SysTrack Mobile Experience vor: IT-Analysen und Telemetriedaten in Echtzeit auf mobilen Geräten
BOSTON, May 19, 2025 (GLOBE NEWSWIRE) -- Lakeside Software, das erste KI-gestützte Unternehmen für digitale Mitarbeitererlebnisse, hat heute die SysTrack Mobile Experience angekündigt, die IT-Telemetrie in Echtzeit, Abfragen in natürlicher Sprache und …

Molecular Partners to Present at Upcoming Investor Conferences
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“ …